
Jared Barsky
Examiner (ID: 7259, Phone: (571)272-2795 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1628 |
| Total Applications | 1117 |
| Issued Applications | 492 |
| Pending Applications | 146 |
| Abandoned Applications | 503 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10676499
[patent_doc_number] => 20160022644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'Oral Transmucosal Compositions Including Aromatase Inhibitors for Treating Female Infertility'
[patent_app_type] => utility
[patent_app_number] => 14/799311
[patent_app_country] => US
[patent_app_date] => 2015-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4252
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14799311
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/799311 | Oral Transmucosal Compositions Including Aromatase Inhibitors for Treating Female Infertility | Jul 13, 2015 | Abandoned |
Array
(
[id] => 10663609
[patent_doc_number] => 20160009753
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-14
[patent_title] => 'Reducing Risk of Contracting Clostridium-Difficile Associated Disease'
[patent_app_type] => utility
[patent_app_number] => 14/798276
[patent_app_country] => US
[patent_app_date] => 2015-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 17599
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14798276
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/798276 | Reducing risk of contracting clostridium-difficile associated disease | Jul 12, 2015 | Issued |
Array
(
[id] => 16138969
[patent_doc_number] => 10702538
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-07
[patent_title] => Ship inhibition to induce activation of natural killer cells
[patent_app_type] => utility
[patent_app_number] => 15/319326
[patent_app_country] => US
[patent_app_date] => 2015-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 14506
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15319326
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/319326 | Ship inhibition to induce activation of natural killer cells | Jun 16, 2015 | Issued |
Array
(
[id] => 10365759
[patent_doc_number] => 20150250764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-10
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS COMPRISING 4-[1-(2,3-DIMETHYLPHENYL)ETHYL]-3HIMIDAZOLE DERIVATIVES FOR TREATING RETINAL DISEASES'
[patent_app_type] => utility
[patent_app_number] => 14/722949
[patent_app_country] => US
[patent_app_date] => 2015-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4233
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14722949
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/722949 | PHARMACEUTICAL COMPOSITIONS COMPRISING 4-[1-(2,3-DIMETHYLPHENYL)ETHYL]-3HIMIDAZOLE DERIVATIVES FOR TREATING RETINAL DISEASES | May 26, 2015 | Abandoned |
Array
(
[id] => 17921520
[patent_doc_number] => 11464741
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-11
[patent_title] => Spray dried compositions having different dissolution profiles and processes for their preparation
[patent_app_type] => utility
[patent_app_number] => 14/722541
[patent_app_country] => US
[patent_app_date] => 2015-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8578
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14722541
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/722541 | Spray dried compositions having different dissolution profiles and processes for their preparation | May 26, 2015 | Issued |
Array
(
[id] => 10457949
[patent_doc_number] => 20150342963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-03
[patent_title] => 'NATURAL COMBINATION HORMONE REPLACEMENT FORMULATIONS AND THERAPIES'
[patent_app_type] => utility
[patent_app_number] => 14/719933
[patent_app_country] => US
[patent_app_date] => 2015-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 26372
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14719933
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/719933 | Natural combination hormone replacement formulations and therapies | May 21, 2015 | Issued |
Array
(
[id] => 10354876
[patent_doc_number] => 20150239882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'NOVEL MONOHYDRATE OF AZAADAMANTANE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/707681
[patent_app_country] => US
[patent_app_date] => 2015-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18809
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14707681
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/707681 | NOVEL MONOHYDRATE OF AZAADAMANTANE DERIVATIVES | May 7, 2015 | Abandoned |
Array
(
[id] => 11713540
[patent_doc_number] => 20170182040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'EPITHELIAL ION CHANNEL (ENAC) BLOCKERS TO TREAT PSORIASIS'
[patent_app_type] => utility
[patent_app_number] => 15/304999
[patent_app_country] => US
[patent_app_date] => 2015-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11919
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15304999
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/304999 | EPITHELIAL ION CHANNEL (ENAC) BLOCKERS TO TREAT PSORIASIS | Apr 30, 2015 | Abandoned |
Array
(
[id] => 17058938
[patent_doc_number] => 11103520
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-31
[patent_title] => Analogs of N-acetlyglucosamine and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/305609
[patent_app_country] => US
[patent_app_date] => 2015-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 16889
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15305609
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/305609 | Analogs of N-acetlyglucosamine and uses thereof | Apr 22, 2015 | Issued |
Array
(
[id] => 11689510
[patent_doc_number] => 20170165226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-15
[patent_title] => 'COMPOSITION COMPRISING AN ESTER OF ALPHA-TOCOPHEROL FOR PREVENTION AND TREATMENT OF ALLERGIC RHINITIS'
[patent_app_type] => utility
[patent_app_number] => 15/325890
[patent_app_country] => US
[patent_app_date] => 2015-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1676
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15325890
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/325890 | COMPOSITION COMPRISING AN ESTER OF ALPHA-TOCOPHEROL FOR PREVENTION AND TREATMENT OF ALLERGIC RHINITIS | Apr 16, 2015 | Abandoned |
Array
(
[id] => 10676543
[patent_doc_number] => 20160022688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'NOVEL USE FOR IMIDAZOTRIAZINONES'
[patent_app_type] => utility
[patent_app_number] => 14/681513
[patent_app_country] => US
[patent_app_date] => 2015-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10317
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14681513
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/681513 | NOVEL USE FOR IMIDAZOTRIAZINONES | Apr 7, 2015 | Abandoned |
Array
(
[id] => 10387882
[patent_doc_number] => 20150272889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-01
[patent_title] => 'Orally Disintegrating Tablet'
[patent_app_type] => utility
[patent_app_number] => 14/679447
[patent_app_country] => US
[patent_app_date] => 2015-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4007
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14679447
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/679447 | Orally Disintegrating Tablet | Apr 5, 2015 | Abandoned |
Array
(
[id] => 12183930
[patent_doc_number] => 20180042867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'METHODS OF TREATING CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/556155
[patent_app_country] => US
[patent_app_date] => 2015-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11765
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15556155
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/556155 | METHODS OF TREATING CANCER | Mar 31, 2015 | Abandoned |
Array
(
[id] => 11895175
[patent_doc_number] => 09765100
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-19
[patent_title] => 'Nucleoside phosphonate salts'
[patent_app_type] => utility
[patent_app_number] => 14/672816
[patent_app_country] => US
[patent_app_date] => 2015-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11254
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14672816
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/672816 | Nucleoside phosphonate salts | Mar 29, 2015 | Issued |
Array
(
[id] => 10346150
[patent_doc_number] => 20150231155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-20
[patent_title] => 'ONAPRISTONE POLYMORPHIC FORMS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 14/661382
[patent_app_country] => US
[patent_app_date] => 2015-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 4409
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14661382
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/661382 | ONAPRISTONE POLYMORPHIC FORMS AND METHODS OF USE | Mar 17, 2015 | Abandoned |
Array
(
[id] => 12283111
[patent_doc_number] => 09931350
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-03
[patent_title] => Anti-infective and osteogenic compositions and methods of use
[patent_app_type] => utility
[patent_app_number] => 14/645040
[patent_app_country] => US
[patent_app_date] => 2015-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 15786
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14645040
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/645040 | Anti-infective and osteogenic compositions and methods of use | Mar 10, 2015 | Issued |
Array
(
[id] => 10987486
[patent_doc_number] => 20160184431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-30
[patent_title] => 'TOPICAL COMPOSITIONS COMPRISING A CORTICOSTEROID'
[patent_app_type] => utility
[patent_app_number] => 14/645297
[patent_app_country] => US
[patent_app_date] => 2015-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10711
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14645297
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/645297 | TOPICAL COMPOSITIONS COMPRISING A CORTICOSTEROID | Mar 10, 2015 | Abandoned |
Array
(
[id] => 10373113
[patent_doc_number] => 20150258119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-17
[patent_title] => 'TOPICAL CORTICOSTEROID COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/645338
[patent_app_country] => US
[patent_app_date] => 2015-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12308
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14645338
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/645338 | TOPICAL CORTICOSTEROID COMPOSITIONS | Mar 10, 2015 | Abandoned |
Array
(
[id] => 10289144
[patent_doc_number] => 20150174142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'MANAGEMENT OF BREAKTHROUGH BLEEDING IN EXTENDED HORMONAL CONTRACEPTIVE REGIMENS'
[patent_app_type] => utility
[patent_app_number] => 14/642096
[patent_app_country] => US
[patent_app_date] => 2015-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5044
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14642096
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/642096 | MANAGEMENT OF BREAKTHROUGH BLEEDING IN EXTENDED HORMONAL CONTRACEPTIVE REGIMENS | Mar 8, 2015 | Abandoned |
Array
(
[id] => 11393895
[patent_doc_number] => 20170014430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-19
[patent_title] => 'Cycloartenol-Containing Composition'
[patent_app_type] => utility
[patent_app_number] => 15/124556
[patent_app_country] => US
[patent_app_date] => 2015-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8312
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15124556
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/124556 | Cycloartenol-Containing Composition | Mar 5, 2015 | Abandoned |